ADPS™ EGFR Mutation Test Kit v1
- Detection target 44 mutations in EGFR exon 18, 19, 20 and 21
- Sample type DNA extracted from FFPE, frozen, and fresh cancer tissue or liquid biopsy
- Detection Sensitivity 0.01~0.1%(FFPET), 10~60copies/mL(plasma)
- Detection Specificity ≥ 99%
INTENDED USE
EGFR mutations are targeted by specific tyrosine kinase inhibitors (TKIs), and the EGFR T790M mutation is used as a resistance biomarker. Therefore, the analysis of EGFR mutations in NSCLC patients can help personalize treatment for patients.
The ADPS™ EGFR Mutation Test Kit v1 detects 44 mutations in exons 18 to 21 of the EGFR gene with a detection sensitivity ranging from 0.01% to 0.1%. It is designed to allow testing of both tissue and plasma samples with a single kit.
- Fast
- Sensitive
- Qualitative
- CE-IVD
Validated Instruments
